Table 3.
Fatty acid | Wild type (µg/mg DW) | Tranc-crdof-12 (µg/mg DW) | Increase (%) | Tranc-gdof-60 (µg/mg DW) | Increase (%) |
---|---|---|---|---|---|
C16:0 | 38.71 ± 0.08 | 58.84 ± 0.02** | 52.01 | 69.49 ± 0.06** | 79.52 |
C16:1 | 2.53 ± 0.03 | 3.84 ± 0.13 | 52.13 | 3.44 ± 0.12 | 36.09 |
C18:0 | 5.44 ± 0.16. | 8.26 ± 0.09 | 51.97 | 4.46 ± 0.08 | − 18.09 |
C18:1 t | 12.19 ± 0.09 | 18.53 ± 0.29 | 51.98 | 28.86 ± 0.01** | 135.13 |
C18:1 c | 12.10 ± 0.07 | 19.39 ± 0.18 | 53.21 | 28.45 ± 0.21** | 135.11 |
C18:2 t | 13.53 ± 0.23 | 19.57 ± 0.03* | 50.01 | 14.32 ± 0.09 | 5.82 |
C18:3n6 | 33.80 ± 0.19 | 51.38 ± 0.25* | 52.01 | 52.37 ± 0.17* | 54.95 |
* Significant increase (P < 0.05) compared with control strain cc849. ** Extremely significant increase (p < 0.01) compared with control strain cc849
#Very significant decline (P < 0.05) compared with control strain cc849